clinicaltrials gov bpc 157 Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157: What you need to
Description
During the examination, bladder contractions and resulting leaks were observed by filling the bladder while simultaneously applying pressure to release fluid at the urethral opening
One patient developed malignant ascites after failure of capecitabine/oxaliplatin treatment
BPC-157 excels at local tissue protection and repair
Using a nasal spray eliminates the need for reconstitution, and dosing is straightforward with the metered spray format
All sequenced samples had their quality evaluated by capillary electrophoresis with Agilent High Sensitivity DNA Kit (Bioanalyzer)
doi: 10.1159/000313740 88
